Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a possible or probable diagnosis of mild cognitive impairment (MCI) or early dementia.
- People aged between 30 and 95 years old.
- People who have a study partner (such as a family member or close friend) who has some contact with them at least once a week.
- People who, in the opinion of the trial doctor, are likely to be able to complete most of the study procedures.
Who may not be able to join:
- People who, in the opinion of the trial doctor, are unable to complete most of the assessments involved in the study.
- People whose symptoms appear to be caused by something other than a neurodegenerative disease — though the trial doctor has the ability to make exceptions to this on a case-by-case basis (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maria C Tartaglia, M.D., Toronto Western Hospital, UHN; Tanz CRND
Phone: 416-603-5914
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognitive phenotype
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.